2025 Q4 -tulosraportti
Vain PDF
98 päivää sitten
Tarjoustasot
Ei dataa
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q2 -tulosraportti 31.8. |
| Menneet tapahtumat | ||
|---|---|---|
2025 Q4 -tulosraportti 15.4. | ||
2025 Q2 -tulosraportti 28.8.2025 | ||
2024 Q4 -tulosraportti 10.4.2025 | ||
2024 Q2 -tulosraportti 29.8.2024 | ||
2023 Q4 -tulosraportti 25.4.2024 |
Asiakkaat katsoivat myös
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
·26 min sittenLOOK AT WHO IS ACTUALLY IN THIS COMPANY. 🧬🌍 People see "Oslo Børs" and think small Norwegian company. So let me show you what's really behind circVec. The lab is located at Karolinska Institute in Stockholm.🇸🇪 Not in a basement — on the campus of one of the world's most renowned medical universities. The very place where the Nobel Prize in Medicine is awarded. And who works there? 👑 CEO Erik Digman Wiklund— co-discoverer of human circular RNA. McKinsey background. Norwegian. 🔬 CTO Thomas Birkballe Hansen— described in the company's own reports simply as a "circRNA discoverer". He is building the platform together with an experienced research team in the Karolinska environment. Danish. 🧠 CSO Victor Levitsky— physician with a PhD in virology, formerly Roche in Zurich, Molecular Partners, Servier in Paris. Internationally recognized expert. Swedish-Russian, resident in Switzerland. Add an Irish-British chairman, a lawyer qualified in both USA and UK, and researchers recruited from all over Europe. 🌍 Do you understand what this is? 👀 It's not "a small Norwegian company". It's an international elite team, put together piece by piece, placed in the middle of one of the world's best research environments — where everyone works on ONE thing: circRNA. That's the winning formula. Not generalists trying a bit of everything. The inventors themselves, plus world experts, hyper-focused on one niche. Ticker on Oslo Børs. Brains from all over the world. 🇳🇴🧠 We know what we own. ♟️🧱🍷Good Benny, Ola Dunk Dunk must be spoon-fed. They can't be bothered to get info themselves. And they don't understand what they can buy until the train has left. How many were sitting on the platforms when it went from 1-14 kr? There was even a fool from Sunnmøre who shorted at 1.04 kr after the emission…! Most of them chicken out along the way. They took profit at 2 kroner and 30 øre.. they talked about overpricing at 2.6 kr, the fools. And still Ola Pottit doesn't understand that the company in a short time can be worth 50-100 kroner, or when they are acquired 250-400 kroner per share. Erik Wiklund said at a price of 14 kroner that this could go ten-bagger again - they say the company is world-leading, They say the value can become immense, But Ola Dunk, or Preben Pottit from Oslo West, he trades at 8 kroner and seventy øre…!? Never mind, when you recognize a success… Then you go in heavily and hold. And you hold when the fools start to dump. Greatreset sat here and talked about a sensation at 0.6 kr 2-3 years ago, he has been with it all the way and knows the company. Listen. I've been in for a long time, some in and out, but since the emission at 1 kr, only in. I repeat, when you recognize a success - then you go in heavily. Then you know what you own🔥- ·2 t sittenThere is a controlled rise by major players, accumulated today before further journey.
·3 t sittencircio's biggest partner is probably the unknown top 5 big pharma player?
·3 t sittenI won't say much as I was on the verge of going crazy in mid-April, but after that rollercoaster ride up and down, I've gained a bit more patience and learned that panic and FOMO only work the opposite of what one wants. Take it easy and buy on the dips and sell a bit on the peaks if you feel you have too much. No one can guarantee anything at all and gut feeling can easily fool the best😊 I have faith, what about you?
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
2025 Q4 -tulosraportti
Vain PDF
98 päivää sitten
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
- ·26 min sittenLOOK AT WHO IS ACTUALLY IN THIS COMPANY. 🧬🌍 People see "Oslo Børs" and think small Norwegian company. So let me show you what's really behind circVec. The lab is located at Karolinska Institute in Stockholm.🇸🇪 Not in a basement — on the campus of one of the world's most renowned medical universities. The very place where the Nobel Prize in Medicine is awarded. And who works there? 👑 CEO Erik Digman Wiklund— co-discoverer of human circular RNA. McKinsey background. Norwegian. 🔬 CTO Thomas Birkballe Hansen— described in the company's own reports simply as a "circRNA discoverer". He is building the platform together with an experienced research team in the Karolinska environment. Danish. 🧠 CSO Victor Levitsky— physician with a PhD in virology, formerly Roche in Zurich, Molecular Partners, Servier in Paris. Internationally recognized expert. Swedish-Russian, resident in Switzerland. Add an Irish-British chairman, a lawyer qualified in both USA and UK, and researchers recruited from all over Europe. 🌍 Do you understand what this is? 👀 It's not "a small Norwegian company". It's an international elite team, put together piece by piece, placed in the middle of one of the world's best research environments — where everyone works on ONE thing: circRNA. That's the winning formula. Not generalists trying a bit of everything. The inventors themselves, plus world experts, hyper-focused on one niche. Ticker on Oslo Børs. Brains from all over the world. 🇳🇴🧠 We know what we own. ♟️🧱🍷Good Benny, Ola Dunk Dunk must be spoon-fed. They can't be bothered to get info themselves. And they don't understand what they can buy until the train has left. How many were sitting on the platforms when it went from 1-14 kr? There was even a fool from Sunnmøre who shorted at 1.04 kr after the emission…! Most of them chicken out along the way. They took profit at 2 kroner and 30 øre.. they talked about overpricing at 2.6 kr, the fools. And still Ola Pottit doesn't understand that the company in a short time can be worth 50-100 kroner, or when they are acquired 250-400 kroner per share. Erik Wiklund said at a price of 14 kroner that this could go ten-bagger again - they say the company is world-leading, They say the value can become immense, But Ola Dunk, or Preben Pottit from Oslo West, he trades at 8 kroner and seventy øre…!? Never mind, when you recognize a success… Then you go in heavily and hold. And you hold when the fools start to dump. Greatreset sat here and talked about a sensation at 0.6 kr 2-3 years ago, he has been with it all the way and knows the company. Listen. I've been in for a long time, some in and out, but since the emission at 1 kr, only in. I repeat, when you recognize a success - then you go in heavily. Then you know what you own🔥
- ·2 t sittenThere is a controlled rise by major players, accumulated today before further journey.
- ·3 t sittencircio's biggest partner is probably the unknown top 5 big pharma player?
- ·3 t sittenI won't say much as I was on the verge of going crazy in mid-April, but after that rollercoaster ride up and down, I've gained a bit more patience and learned that panic and FOMO only work the opposite of what one wants. Take it easy and buy on the dips and sell a bit on the peaks if you feel you have too much. No one can guarantee anything at all and gut feeling can easily fool the best😊 I have faith, what about you?
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Ei dataa
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q2 -tulosraportti 31.8. |
| Menneet tapahtumat | ||
|---|---|---|
2025 Q4 -tulosraportti 15.4. | ||
2025 Q2 -tulosraportti 28.8.2025 | ||
2024 Q4 -tulosraportti 10.4.2025 | ||
2024 Q2 -tulosraportti 29.8.2024 | ||
2023 Q4 -tulosraportti 25.4.2024 |
2025 Q4 -tulosraportti
Vain PDF
98 päivää sitten
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q2 -tulosraportti 31.8. |
| Menneet tapahtumat | ||
|---|---|---|
2025 Q4 -tulosraportti 15.4. | ||
2025 Q2 -tulosraportti 28.8.2025 | ||
2024 Q4 -tulosraportti 10.4.2025 | ||
2024 Q2 -tulosraportti 29.8.2024 | ||
2023 Q4 -tulosraportti 25.4.2024 |
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
- ·26 min sittenLOOK AT WHO IS ACTUALLY IN THIS COMPANY. 🧬🌍 People see "Oslo Børs" and think small Norwegian company. So let me show you what's really behind circVec. The lab is located at Karolinska Institute in Stockholm.🇸🇪 Not in a basement — on the campus of one of the world's most renowned medical universities. The very place where the Nobel Prize in Medicine is awarded. And who works there? 👑 CEO Erik Digman Wiklund— co-discoverer of human circular RNA. McKinsey background. Norwegian. 🔬 CTO Thomas Birkballe Hansen— described in the company's own reports simply as a "circRNA discoverer". He is building the platform together with an experienced research team in the Karolinska environment. Danish. 🧠 CSO Victor Levitsky— physician with a PhD in virology, formerly Roche in Zurich, Molecular Partners, Servier in Paris. Internationally recognized expert. Swedish-Russian, resident in Switzerland. Add an Irish-British chairman, a lawyer qualified in both USA and UK, and researchers recruited from all over Europe. 🌍 Do you understand what this is? 👀 It's not "a small Norwegian company". It's an international elite team, put together piece by piece, placed in the middle of one of the world's best research environments — where everyone works on ONE thing: circRNA. That's the winning formula. Not generalists trying a bit of everything. The inventors themselves, plus world experts, hyper-focused on one niche. Ticker on Oslo Børs. Brains from all over the world. 🇳🇴🧠 We know what we own. ♟️🧱🍷Good Benny, Ola Dunk Dunk must be spoon-fed. They can't be bothered to get info themselves. And they don't understand what they can buy until the train has left. How many were sitting on the platforms when it went from 1-14 kr? There was even a fool from Sunnmøre who shorted at 1.04 kr after the emission…! Most of them chicken out along the way. They took profit at 2 kroner and 30 øre.. they talked about overpricing at 2.6 kr, the fools. And still Ola Pottit doesn't understand that the company in a short time can be worth 50-100 kroner, or when they are acquired 250-400 kroner per share. Erik Wiklund said at a price of 14 kroner that this could go ten-bagger again - they say the company is world-leading, They say the value can become immense, But Ola Dunk, or Preben Pottit from Oslo West, he trades at 8 kroner and seventy øre…!? Never mind, when you recognize a success… Then you go in heavily and hold. And you hold when the fools start to dump. Greatreset sat here and talked about a sensation at 0.6 kr 2-3 years ago, he has been with it all the way and knows the company. Listen. I've been in for a long time, some in and out, but since the emission at 1 kr, only in. I repeat, when you recognize a success - then you go in heavily. Then you know what you own🔥
- ·2 t sittenThere is a controlled rise by major players, accumulated today before further journey.
- ·3 t sittencircio's biggest partner is probably the unknown top 5 big pharma player?
- ·3 t sittenI won't say much as I was on the verge of going crazy in mid-April, but after that rollercoaster ride up and down, I've gained a bit more patience and learned that panic and FOMO only work the opposite of what one wants. Take it easy and buy on the dips and sell a bit on the peaks if you feel you have too much. No one can guarantee anything at all and gut feeling can easily fool the best😊 I have faith, what about you?
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Ei dataa
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt